Real-world evidence to improve outcomes for people with cancer
At Syapse, our goal is to realize the promise of precision medicine — helping to deliver the best care to every cancer patient by harnessing powerful real-world evidence.
What we do
Syapse is a real-world evidence company working in partnership with health systems, life sciences companies, and regulators to solve the challenges of precision medicine and drive better outcomes for people with cancer around the world.
-
A focus on the right clinical and molecular data to generate high-quality insights: unlocking value from complex, previously unstructured data and enabling providers to operationalize precision medicine.
-
A web-based tool for exploring shared, de-identified real-world data enables study feasibility assessments, identification of unmet need, post-market usage characterization, and more.
-
Through the Learning Health Network, health systems access and apply real-world insights and best practices; life sciences companies can leverage insights to aid in producing effective therapies and regulators can set frameworks for the use of real-world data.
Executive Leadership
Senior Leadership
Board of Directors
John Kuelper
Director, Ascension Ventures
Gary J. Kurtzman, MD
Managing Director, Safeguard Scientifics
Zack Scott
Managing Partner, Revelation Partners
Ken Tarkoff
Chief Executive Officer, Syapse
Robin Toft
Founder and CEO, Toft Group
Frank Williams
CEO, Evolent Health
Jay Zaveri
Partner, Social Capital
Investors
Careers
Join us in the fight against cancer.
Learn more about life at Syapse, perks, and open opportunities.